Secondary malignant neoplasm of large intestine
Item
metastatic colorectal cancer
boolean
C0346973 (UMLS CUI [1])
Disease Progression | Status post Standard of Care Quantity | Intolerance to Irinotecan
Item
progression after at least one prior standard of care regimen or be intolerant to irinotecan-based regimens
boolean
C0242656 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C2936643 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1744706 (UMLS CUI [3,1])
C0123931 (UMLS CUI [3,2])
Life Expectancy
Item
life expectancy ≥ 3 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status ≤ 2
boolean
C1520224 (UMLS CUI [1])
Leptomeningeal disease Symptomatic | Leptomeningeal disease Untreated
Item
symptomatic or untreated leptomeningeal disease
boolean
C0751297 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0751297 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Diabetes Mellitus
Item
patients with clinically manifested diabetes
boolean
C0011849 (UMLS CUI [1])
Pancreatitis | Pancreatitis, Chronic
Item
acute or chronic pancreatitis
boolean
C0030305 (UMLS CUI [1])
C0149521 (UMLS CUI [2])
Heart Disease
Item
clinically significant cardiac disease
boolean
C0018799 (UMLS CUI [1])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])